HCP
49
4
WYNN
42
14
FDX
40
3
PEG
53
-2
PLD
56
13
IVZ
45
2
HST
32
2
MNST
59
2
GM
29
2
UNH
38
-4
GME
59
3
FSLR
46
2
AAPL
65
3
AMGN
26
-4
CI
59
-6
CTSH
54
2
BBY
56
4
GS
62
2
PAYX
44
-6
CF
41
2
HCP
49
4
WYNN
42
14
FDX
40
3
PEG
53
-2
PLD
56
13
IVZ
45
2
HST
32
2
MNST
59
2
GM
29
2
UNH
38
-4
GME
59
3
FSLR
46
2
AAPL
65
3
AMGN
26
-4
CI
59
-6
CTSH
54
2
BBY
56
4
GS
62
2
PAYX
44
-6
CF
41
2
Financhill
Back

Royal Caribbean Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
76

RCL
Royal Caribbean Group

Last Price:
$260.04
Seasonality Move:
3.54%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.14
Seasonality Move:
1.75%
Buy
76
Royal Caribbean Group (RCL) is a Buy

Is Royal Caribbean Group a Buy, Sell or Hold?

  • The current Royal Caribbean Group [RCL] share price is $263.09. The Score for RCL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • RCL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCL Stock Price Chart

What is Royal Caribbean Group's stock price today?

  • The Royal Caribbean Group share price today is $263.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.21 Buy
Relative Strength Index (14 RSI): 59 Buy
Chaikin Money Flow: 923540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (235.42 - 266.74) Buy
Bollinger Bands (100): (199.44 - 253.2) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

RCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 262.35 Buy
20-day SMA: 256.37 Buy
50-day SMA: 244.89 Buy
200-day SMA: 190.72 Buy
8-day EMA: 260.87 Buy
20-day EMA: 256.01 Buy
50-day EMA: 244.52 Buy
200-day EMA: 198.87 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Royal Caribbean Group Earnings Growth & RCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $2.89 per share, an increase this year of $3.18 per share, and an increase next year of $2.59 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Royal Caribbean Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):